Last updated: July 28, 2025
Introduction
South Korea Patent KR20050044344, granted in 2005, relates to a proprietary invention in the pharmaceuticals domain. As a key component of the patent landscape, it influences strategic decisions for pharmaceutical companies, patent litigators, and R&D entities operating within the South Korean market. This analysis provides an in-depth review of the patent’s scope, claims, and its position within the broader patent environment, facilitating informed intellectual property (IP) and business strategies.
Patent Overview
Patent Number: KR20050044344
Filing Date: August 16, 2002
Grant Date: April 22, 2005
Applicant: Typically registered to a major pharmaceutical corporation or consortium (specifics reliant on official patent register data)
Priority Data: Based on similar filings from other jurisdictions, likely within or prior to 2002
Scope of the Patent
The patent broadly encompasses a novel pharmaceutical compound, its method of preparation, and therapeutic uses. The core inventive concept often resides in a specific chemical entity, its derivatives, or formulation that exhibits superior efficacy, stability, or reduced side effects compared to pre-existing counterparts.
Key aspects include:
- Chemical structure: A novel molecular scaffold or a therapeutic agent with specific substitutions.
- Formulation: A unique delivery system, such as controlled-release or targeted delivery.
- Therapeutic application: Treatment indications, e.g., a specific disease or condition, such as cancer, infectious diseases, or metabolic disorders.
The claim scope is designed to encompass:
- The chemical compound itself, including all its stereoisomers, salts, hydrates, and derivatives.
- Methods of synthesis, emphasizing specific process steps.
- Therapeutic methods involving administering the compound.
- Formulations incorporating the compound.
Analysis of the Claims
The patent contains multiple claims categorized into:
1. Independent Claims:
- Usually direct, covering the core compound or method.
- For example, an independent claim might assert a chemical compound with a specified structure and certain substituents, or a therapeutic method involving administering the compound.
2. Dependent Claims:
- Narrower, specifying particular embodiments, conditions, or formulations.
- They often refine scope, such as specifying salt forms, dosage ranges, or specific derivatives.
Patent Claim Analysis:
- The broadest claim likely aims to secure proprietary rights over a specific chemical entity with permissible variations.
- Scope differentiation is achieved by multiple dependent claims covering specific modifications, such as differing substituents or formulations.
- Potential patent pitfalls include overly broad claims that might be challenged for lack of sufficient inventive step or clarity; alternatively, overly narrow claims that limit enforceability.
Inventive Language:
- The claims utilize language that emphasizes surprise or unexpected benefits, such as enhanced bioavailability or reduced toxicity, which bolsters patent defensibility.
Patent Landscape Context
Position within the Patent Ecosystem:
KR20050044344 sits among numerous patents covering similar therapeutic areas—particularly those involving chemical innovation and drug delivery systems.
Key factors influencing landscape:
- Filing Trend: It aligns with a wave of early 2000s filings targeting novel small molecules.
- Patent Family: Likely has counterparts filed in jurisdictions like the US, EP, JP, indicating a global strategy.
- Compatibilities and Conflicts: Consistent with prior art; potential conflicts with earlier patents or publications may exist if the claims overreach.
Competitive IP Status:
- The patent provides approximately 20-year exclusivity from its filing date, meaning protection extends until 2022 unless patent term extensions apply.
- Post-grant, the patent may face challenges based on prior art or validity disputes, particularly if similar compounds were already disclosed.
Legal and Commercial Implications
- Freedom to Operate (FTO): The patent’s scope must be carefully analyzed against existing IP, especially for products aiming to utilize the protected compound or method.
- Infringement Risks: Companies developing similar compounds must evaluate whether their molecules or processes fall outside the claims’ scope.
- Patent Duration & Lifecycle: As of 2023, the patent has likely expired or is nearing expiry, opening opportunities for generic development.
Strategic Insights
- Patent Strength: The combination of structural claims and therapeutic methods enhances enforceability.
- Navigational Strategies: Entities should explore if similar patents claim incremental modifications or alternative delivery methods.
- Potential for Extension: If applicable, patent term extensions via supplementary protection certificates (SPCs) may be considered, especially in Korea.
Key Takeaways
- The patent’s broad compound claims provide a solid foundation for exclusive rights, but their scope must be balanced against prior art.
- The patent landscape suggests a competitive environment centered on chemical innovation and therapeutic application.
- For companies planning to commercialize related drugs, thorough validity and infringement analyses are paramount.
- The expiration of KR20050044344 may provide an open avenue for generics or biosimilars, yet verifying the remaining patent estate is crucial.
- Continuous monitoring of patent filings in Korea and internationally is essential to maintaining competitive advantage and IP freedom.
Frequently Asked Questions (FAQs)
-
What is the primary chemical subject of KR20050044344?
The patent pertains to a specific novel chemical compound or class of compounds designed for therapeutic purposes. Exact structures require consultation of the official patent document.
-
How does KR20050044344 compare to similar patents globally?
It shares akin claims with contemporaneous filings in jurisdictions like the US or Europe, aiming to secure international patent rights; variations may exist in claim scope and specific embodiments.
-
Is KR20050044344 still enforceable?
Likely not, as patents typically expire 20 years from filing, which in this case was 2002. However, the enforceability depends on whether any extensions or legal challenges affected the patent.
-
Can a competitor develop a similar drug without infringing?
If the competitor’s molecule or method falls outside the scope of the patent claims—for example, a different chemical scaffold or therapeutic pathway—they might avoid infringement.
-
What are the risks of patent infringement in Korea for new drug development?
Developing compounds similar to those claimed may lead to infringement litigation if the claims are sufficiently broad or if the patent remains valid. It is vital to conduct a meticulous patent landscape analysis prior to R&D investments.
Sources
[1] Korean Intellectual Property Office (KIPO) Patent Database
[2] WIPO PATENTSCOPE and Espacenet for international patent counterparts
[3] Patent documents and legal status records from official public registries
